Founding Member

Julie brings 7 years of bench science, healthcare management consulting, and pharma equity research experience to her associate director role at EFL. She also spent time in seed-stage life science investing, where she developed a passion for startups and growing the opportunities for early stage companies in NYC. Julie holds a Ph.D. in Pathology from NYU School of Medicine, where she studied immunotherapy and radiation for the treatment of cancer.